Professor Francesc Bosch is the Head of the Department of Hematology at the University Hospital Vall d’Hebron, Barcelona, ES, and a Professor in the Department of Medicine at Universitat Autònoma de Barcelona, Barcelona, ES.

He completed his medical degree in 1988 at Universitat de Barcelona, Barcelona, ES, after which he underwent postgraduate training in hematology at the Hospital Clinic of Barcelona, finishing in 1992. In 1998, Prof. Bosch was awarded his PhD by the Universitat de Barcelona — his thesis was titled ‘Cyclin D1 gene in chronic lymphoproliferative disorders’. From 1998 until 2000, Prof. Bosch undertook a postdoctoral research position at the Institute for Cancer Genetics, Columbia University, NY, US, after which he returned to Barcelona to continue researching chronic lymphocytic leukemia (CLL).

Prof. Bosch was made Head of the Department of Hematology at the University Hospital Vall d’Hebron, Barcelona, ES, in 2009, where his research focuses on the molecular pathogenesis of CLL and the development of novel therapeutic approaches. He has been involved in the development of clinical trials, currently as Chair of the Spanish Group of CLL (GELLC), which is responsible for the development of Spanish CLL trials. Besides this, he has published more than 100 papers in peer-reviewed journals, including the New England Journal of Medicine (NEJM), Nature Medicine, Blood and the Journal of Clinical Oncology, among others. He has also authored or co-authored a number of reviews and book chapters on the subject of CLL and other lymphoproliferative disorders.

Positions of responsibility/awards:

Chair of the Spanish Group of CLL (GELLC)
Principal Investigator of Vall d’Hebron Institute of Oncology’s Experimental Hematology Group since 2016
Main organizer of the Young Investigator’s Group on CLL, 2007
Member of the European Project for Mantle Cell Lymphoma, 1996
Founder Member of the Grup d’Estudi dels Linfomes a Catalunya i Balears (GELCAB), 1996
Young Investigator Award, Paris, from the European Hematology Association, 1996
Young Investigator Award from the Catalan Society of Hematology and Hemotherapy, 1994
Extraordinary Doctorate Award, 1998, for his PhD studies

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Pembrolizumab

Pembrolizumab

All Interventions